Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10077431 Phage therapy of pseudomonas infections

Patent 10077431 was granted and assigned to Pherecydes Pharma on September, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 8 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 8 Dec, 2023
Edits made to:
Article (+320 characters)
Article

Patent abstract

The present invention relates to bacteriophage therapy. More particularly, the present invention relates to novel bacteriophages having a high specificity against Pseudomonas aeruginosa strains, their manufacture, components thereof, compositions comprising the same and the uses thereof in phage therapy.

Edits on 11 Oct, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11779617 Phage therapy
Edits on 1 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 1 Oct, 2023
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Flavie Pouillot0
Hélène Blois0
Edits on 5 Jul, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 5 Jul, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11690885 Anti-bacterial compositions and uses thereof
0
Edits on 27 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Apr, 2023
Infobox
Patent Citations Received
‌
US Patent 10918680 Phage therapy of
0
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Infobox
Patent Citations Received
‌
US Patent 10898530 Phage therapy
0
Edits on 24 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Pherecydes Pharma
Pherecydes Pharma
0
Current Assignee
Pherecydes Pharma
Pherecydes Pharma
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
100774310
Date of Patent
September 18, 2018
0
Patent Application Number
150317630
Date Filed
October 24, 2014
0
Patent Citations Received
‌
US Patent 10898530 Phage therapy
0
‌
US Patent 10918680 Phage therapy of
0
Patent Primary Examiner
‌
Barry A Chestnut
0
Edits on 10 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 10 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10918680 Phage therapy of
Edits on 9 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10898530 Phage therapy
Edits on 22 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 22 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10077431 Phage therapy of pseudomonas infections

Infobox
Is a
Patent
Patent
Patent applicant
Pherecydes Pharma
Pherecydes Pharma
Current assignee
Pherecydes Pharma
Pherecydes Pharma
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10077431
Date of patent
September 18, 2018
Patent application number
15031763
Date Filed
October 24, 2014
Patent primary examiner
‌
Barry A Chestnut

Find more entities like US Patent 10077431 Phage therapy of pseudomonas infections

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.